公开(公告)号：WO2021186243A1

公开(公告)日：2021-09-23

申请号：PCT/IB2021/000149

申请日：2021-03-19

Applicant: SKINGEN INTERNATIONAL INC.

Inventor： BRYANT, David ,  GUILBAUD, Paul

IPC: A61K8/64 ,  A61K8/06 ,  A61K8/11 ,  A61K8/55 ,  A61K8/66 ,  A61K8/67 ,  A61K8/73 ,  A61K8/9789 ,  A61K8/99 ,  A61Q19/08 ,  C07K14/475

Abstract: Aqueous topical and transdermal skin care compositions comprising at least 5 recombinant human growth factors are disclosed. The compositions are useful for repairing and/or regenerating the skin, thereby improving its appearance and treating signs of aging due to various external factors (such as UV exposure). The recombinant human growth factors are selected from the group consisting of HGF, FG2, aFGF, IGF2, Mini EGF, IGF1, FGF-10, TGF-β3, PDGF, KGF, EGF-1, Stem Cell Factor, and Mini Noggin. Each growth factor, when present, is present in a concentration ranging from 0.001 to 1 wt. % of the overall composition.